Immunoprofiling of these tumors showed that MSA-2+anti-D-1 combination did not affect the numbers of CD4+ T cells or tumor-associated F4/80-positive macrophages (Supplementary Fig. 7b, c). Here, CD4 is linked to neoplasm.